
zzso of the present phase II zzso study was to verify whether zzso might be able to prevent acute and especially delayed zzso for either zzso or zzso starting from the second chemotherapy cycle, in patients who had failed to respond to a different zzso zzso zzso during the first zzso zzso factor was age zzso years zzso zzso or zzso years of patients zzso zzso cancer patients zzso elderly and 24 zzso scheduled to receive zzso or zzso regimens who had experienced zzso grade zzso during the first chemotherapy course and for whom the same course of chemotherapy regimen was further scheduled were zzso Complete response zzso and complete control zzso rates for the zzso delayed and overall zzso of zzso were not significantly different between elderly and zzso zzso zzso was zzso only grade 1-2 zzso were observed with a peak of zzso for zzso with no significant difference between elderly and zzso zzso In conclusion, single dose zzso zzso zzso should be considered a safe and effective second generation zzso zzso in the prevention of zzso and vomiting induced by zzso or zzso irrespective of patients' zzso 

